Target intelligence / Profile preview

Nucleolin–ribosomal DNA G-quadruplex complex (NCL–rDNA G4 complex)

Target
NCL–rDNA G4 complex
Molecular classification
Transcription factor, Other
01

Overview

The Nucleolin–ribosomal DNA (rDNA) G-quadruplex (G4) complex is a regulatory assembly where the multifunctional protein nucleolin binds to G-rich sequences in rDNA that fold into four-stranded G4 structures (Hannan et al., 2013, Nature Reviews Drug Discovery). This interaction is a key regulator of RNA polymerase I (Pol I) transcription, which is responsible for synthesizing the precursor to ribosomal RNA (rRNA) (Ugrinova et al., 2018, Molecules). In cancer cells, nucleolin is often overexpressed and localized to these G4 sites to maintain the high levels of ribosome biogenesis required for rapid proliferation (Drygin et al., 2010, Cancer Research). Small molecules like CX-5461 (Pidnarulex) and CX-3543 (Quarfloxin) target this complex by stabilizing the G4 structures or displacing nucleolin, thereby inhibiting Pol I transcription and inducing nucleolar stress (Quin et al., 2016, Oncotarget). This disruption activates the DNA damage response and p53-dependent or independent apoptotic pathways, making the complex a significant target for anti-cancer therapy (Bywater et al., 2012, Cancer Cell). Beyond rDNA, nucleolin's interaction with G4s in promoter regions of oncogenes like c-MYC further underscores its importance in oncogenic signaling (Gonzalez and Hurley, 2010, Annual Review of Pharmacology and Toxicology). Targeting this specific protein-DNA interface offers a strategy to selectively impair the hyperactivated translational machinery of malignant cells while sparing normal cells to some extent.

Other names
Nucleolin–rDNA G4 complexNCL–G4 complexNucleolin–G-quadruplex interactionNucleolin–rDNA G-quadruplex complexNCL-rDNA G-quadruplex complex
02

Mechanism of action

Stabilization of G-quadruplex structures and displacement of nucleolin to inhibit RNA polymerase I-mediated transcription and induce nucleolar stress.

03

Biological functions

Cell proliferationApoptosisOther
04

Disease associations

Cancer
05

Safety considerations

Hematological toxicityNeutropeniaOff-target DNA damageInhibition of normal ribosome biogenesis
06

Interacting drugs

Pidnarulex (CX-5461)

2 more in the full profile.

07

Biomarkers

Nucleolin expression45S pre-rRNA levelsp53 statusG-quadruplex density

Beyond the preview

Go deeper on Nucleolin–ribosomal DNA G-quadruplex complex (NCL–rDNA G4 complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleolin–ribosomal DNA G-quadruplex complex (NCL–rDNA G4 complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call